Khác

Vox Markets Interview with Avacta CEO Alastair Smith

0

0

0 Lượt xem· 09/19/23

The Vox Markets Podcast
0 Người đăng ký

Trong

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

Cho xem nhiều hơn

0 Bình luận

Tiếp theo

Tự chạy

Nhà

Tìm hiểu thêm

Cứu giúp